FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 203 filers reported holding FIBROGEN INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $525,960 | -85.4% | 194,800 | +1.1% | 0.00% | -100.0% |
Q1 2023 | $3,593,916 | +4.3% | 192,600 | -10.4% | 0.00% | 0.0% |
Q4 2022 | $3,444,300 | +25.9% | 215,000 | +2.3% | 0.00% | 0.0% |
Q3 2022 | $2,735,000 | +24.8% | 210,200 | +1.3% | 0.00% | +100.0% |
Q2 2022 | $2,191,000 | -7.6% | 207,500 | +5.2% | 0.00% | 0.0% |
Q1 2022 | $2,372,000 | -8.2% | 197,300 | +7.7% | 0.00% | -50.0% |
Q4 2021 | $2,583,000 | +38.0% | 183,200 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $1,872,000 | -61.1% | 183,200 | +1.5% | 0.00% | -66.7% |
Q2 2021 | $4,807,000 | -26.0% | 180,500 | -3.5% | 0.00% | -25.0% |
Q1 2021 | $6,494,000 | -4.8% | 187,100 | +1.7% | 0.00% | -20.0% |
Q4 2020 | $6,821,000 | -8.8% | 183,900 | +1.2% | 0.01% | -16.7% |
Q3 2020 | $7,476,000 | +5.3% | 181,800 | +3.8% | 0.01% | 0.0% |
Q2 2020 | $7,101,000 | +34.2% | 175,200 | +15.0% | 0.01% | 0.0% |
Q1 2020 | $5,292,000 | -17.6% | 152,300 | +1.7% | 0.01% | -14.3% |
Q4 2019 | $6,425,000 | +19.1% | 149,800 | +2.7% | 0.01% | +16.7% |
Q3 2019 | $5,395,000 | -16.7% | 145,900 | +1.8% | 0.01% | -14.3% |
Q2 2019 | $6,474,000 | -14.5% | 143,300 | +2.8% | 0.01% | -12.5% |
Q1 2019 | $7,576,000 | +22.0% | 139,400 | +3.9% | 0.01% | 0.0% |
Q4 2018 | $6,211,000 | -22.0% | 134,200 | +2.4% | 0.01% | -11.1% |
Q3 2018 | $7,964,000 | -1.8% | 131,100 | +1.2% | 0.01% | 0.0% |
Q2 2018 | $8,107,000 | +44.7% | 129,500 | +6.8% | 0.01% | +28.6% |
Q1 2018 | $5,604,000 | +3.3% | 121,300 | +6.0% | 0.01% | +16.7% |
Q4 2017 | $5,423,000 | -10.5% | 114,400 | +1.6% | 0.01% | -14.3% |
Q3 2017 | $6,058,000 | +89.3% | 112,600 | +13.6% | 0.01% | +75.0% |
Q2 2017 | $3,201,000 | +57.2% | 99,100 | +20.0% | 0.00% | +33.3% |
Q1 2017 | $2,036,000 | +18.9% | 82,600 | +3.2% | 0.00% | 0.0% |
Q4 2016 | $1,712,000 | +3.4% | 80,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,656,000 | +26.1% | 80,000 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $1,313,000 | -20.1% | 80,000 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $1,643,000 | -15.0% | 80,000 | +26.2% | 0.00% | -40.0% |
Q4 2015 | $1,932,000 | +41.4% | 63,400 | +1.8% | 0.01% | +25.0% |
Q3 2015 | $1,366,000 | +469.2% | 62,300 | +510.8% | 0.00% | +300.0% |
Q2 2015 | $240,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |